Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
ORAGENICS (NYSE: OGEN) Delayed: 0.50 -0.01 (1.96%)
Previous Close $0.51    52 Week High $2.12 
Open $0.51    52 Week Low $0.33 
Day High $0.52    P/E N/A 
Day Low $0.50    EPS $-0.45 
Volume 22,885